Organon (OGN) Cash from Investing Activities (2020 - 2025)
Historic Cash from Investing Activities for Organon (OGN) over the last 6 years, with Q3 2025 value amounting to -$115.0 million.
- Organon's Cash from Investing Activities fell 5333.33% to -$115.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$621.0 million, marking a year-over-year decrease of 10838.93%. This contributed to the annual value of -$513.0 million for FY2024, which is 9730.77% down from last year.
- Per Organon's latest filing, its Cash from Investing Activities stood at -$115.0 million for Q3 2025, which was down 5333.33% from -$38.0 million recorded in Q2 2025.
- Organon's 5-year Cash from Investing Activities high stood at -$38.0 million for Q1 2021, and its period low was -$296.0 million during Q4 2024.
- For the 5-year period, Organon's Cash from Investing Activities averaged around -$105.2 million, with its median value being -$75.0 million (2024).
- Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 42978.72% in 2021, then skyrocketed by 7417.84% in 2023.
- Over the past 5 years, Organon's Cash from Investing Activities (Quarter) stood at -$133.0 million in 2021, then soared by 54.14% to -$61.0 million in 2022, then plummeted by 32.79% to -$81.0 million in 2023, then plummeted by 265.43% to -$296.0 million in 2024, then skyrocketed by 61.15% to -$115.0 million in 2025.
- Its last three reported values are -$115.0 million in Q3 2025, -$38.0 million for Q2 2025, and -$172.0 million during Q1 2025.